Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD40 C-terminal-like protein (ANKRD40CL) is a member of the ankyrin repeat domain protein family. The gene is located on human chromosome 17 and is sometimes referred to by its aliases C17orf73 and LINC00483, the latter denoting a long noncoding RNA. The protein is predicted to contain ankyrin repeat domains, which may serve as scaffolds for protein-protein interactions[1]. Research has linked elevated gene expression to several cancers, including pancreatic ductal adenocarcinoma, cervical and colorectal cancer, with potential biomarker relevance[4][8][2]. However, the entity is not classified as a receptor, enzyme, ion channel, or recognized drug target, and its precise biological function remains poorly characterized[4][1][8]. In summary, ANKRD40CL is best described as a gene/protein of the ankyrin repeat family with ambiguous molecular classification (sometimes annotated as noncoding RNA), but it is not a validated therapeutic target, receptor, or enzyme[1][4][8][9].
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD40 C-terminal-like protein (ANKRD40CL).